Category: 151004-88-5

Application of 151004-88-5, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.151004-88-5, Name is (R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid, molecular formula is C18H17NO4. In a Patent£¬once mentioned of 151004-88-5

GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure formula (I) wherein R1a, R1b, R2a , R2b, R3, R4, R5, R6, R7 and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 151004-88-5, and how the biochemistry of the body works.Application of 151004-88-5

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. HPLC of Formula: C18H17NO4. Introducing a new discovery about 151004-88-5, Name is (R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid

Enantioselective addition of vinylzinc reagents to 3,4-dihydroisoquinoline N-oxide

Ligand 2a promotes the enantioselective addition of vinylzinc reagents to 3,4-dihydroisoquinoline N-oxide to yield chiral allylic hydroxylamines. With 0.1 equiv of the ligand, the product is obtained in up to 84% ee, whereas with 1.2 equiv of the ligand, the ee is increased to the 90-95% range with a variety of aliphatic, cyclic, and aromatic vinylzinc reagents. This method was used to synthesize the protected unnatural amino acid M-Cbz-D-1,2,3,4- tetrahydroisoquinoline-1-carboxylic acid in three steps from the allylic hydroxylamine.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.HPLC of Formula: C18H17NO4, you can also check out more blogs about151004-88-5

Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.151004-88-5,(R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid,as a common compound, the synthetic route is as follows.

To N-Benzyloxycarbonyl-D-1,2, 3, 4-tetrahydro-isoquinoline-1-carboxylic acid (3.11 g, 10 mmol, made from commercially available D-1,2, 3, 4-tetrahydro- ISOQUINOLINE-1-CARBOXYLIC acid and O-BENZYLOXYCARBONYL-N-HYDROXYSUCCINAMIDE) in THF (10 mL) was added BH3 (1M solution in THF; 30 mL, 30 mmol) over 5 min, and the reaction mixture was stirred for 3 hours. Acetic acid (9 mL) in MEOH (90 mL) was added and the mixture was stirred for 30 min. Solvents were evaporated, the residue was taken up in EtOAc and was washed with saturated aqueous NAHC03 (90 mL, aq. phase pH 7-8) and brine. The organic layer was dried over NA2S04 and concentrated to give compound 13a (2.97 g, 100%). MS (CI) M/Z 253.9 (MH+-CO2), 297. 9 (MH+) ; TR = 2.695 min (method 4)., 151004-88-5

The synthetic route of 151004-88-5 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; NEUROCRINE BIOSCIENCES, INC.; WO2005/7164; (2005); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem